VALIANT (VALsartan In Acute myocardial iNfarcTion) trial

Author： Maggioni Aldo Pietro   Fabbri Gianna  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.3, 2005-03, pp. : 507-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology and clinical trial results of lanoteplase in acute myocardial infarction

By Llevadot J.   Giugliano R.P.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2689-2694

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology and clinical trial results of saruplase (scuPA) in acute myocardial infarction

By Moser M.   Bode C.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 329-335

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population

By Benge Cassandra D   Muldowney James A S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1469-1482

Informa Healthcare

Access to resources Recommend Favorite

Alcohol and Acute Myocardial Infarction

By Biyik I   Ergene O  

The Journal of International Medical Research, Vol. 35, Iss. 1, 2007-01 ,pp. : 46-51

Field House Publishing

Access to resources Recommend Favorite

Acetaminophen and Experimental Acute Myocardial Infarction

By Hale Sharon   Kloner Robert  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 2, 2004-03 ,pp. : 121-125

Springer Publishing Company

Access to resources Recommend Favorite